Fibrocell Science Inc (FCSC) 2013年年度报告「NASDAQ」.pdf

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K xAnnual Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934 For the fiscal year ended December 31,2013 OR Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934 Fib

2、rocell Science,Inc.(Exact name of registrant as specified in its Charter.)Delaware(State or other jurisdictionof incorporation)001-31564(Commission File Number)87-0458888(I.R.S.EmployerIdentification No.)405 Eagleview BoulevardExton,Pennsylvania 19341(Address of principal executive offices,including

3、 zip code)(484)713-6000(Issuers telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of Each ClassName of each exchange on which registeredCommon Stock,$.001 par valueNYSE MKT Securities registered pursuant to Section 12(g)of the Act:NoneIndicate by ch

4、eck mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes No x Indicate by check mark whether the registrant:(1)filed

5、all reports required to be filed by Section 13 or 15(d)of the Exchange Act during thepreceding 12 months(or for any shorter period that the registrant was required to file such reports),and(2)has been subject to such filingrequirements for the past 90 days.Yes x No Indicate by check mark whether the

6、 registrant has submitted electronically and posted on its corporate Web site,if any,every Interactive DataFile required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was require